<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03684928</url>
  </required_header>
  <id_info>
    <org_study_id>EX-MKTG-94</org_study_id>
    <nct_id>NCT03684928</nct_id>
  </id_info>
  <brief_title>A Bilateral Dispensing Comparison of Comfilcon A Over Senofilcon C Contact Lenses</brief_title>
  <official_title>A Bilateral Dispensing Comparison of Biofinity Toric and Acuvue Vita for Astigmatism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the subjective acceptance of Comfilcon A contact lenses
      when worn on a daily wear modality over one month.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a 30-subjects prospective, double-masked (investigator and participant),
      bilateral, randomized, one month cross-over dispensing study comparing subject acceptance of
      Comfilcon A against Senofilcon A contact lenses.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 23, 2018</start_date>
  <completion_date type="Actual">February 1, 2019</completion_date>
  <primary_completion_date type="Actual">December 14, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Prospective, double-masked, bilateral, randomized, one month cross-over dispensing study.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ease of Insertion(Handling)</measure>
    <time_frame>Baseline</time_frame>
    <description>Subjective ratings of ease of insertion for each pair of lenses (scale: 0-10; 0= Very difficult,10 = Very easy)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ease of Insertion (Handling)</measure>
    <time_frame>2 weeks</time_frame>
    <description>Subjective ratings of ease of insertion for each pair of lenses (scale: 0-10; 0= Very difficult,10 = Very easy)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ease of Insertion(Handling)</measure>
    <time_frame>1 month</time_frame>
    <description>Subjective ratings of ease of insertion for each pair of lenses (scale: 0-10; 0= Very difficult,10 = Very easy)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rotational Recovery After Lens Mislocation</measure>
    <time_frame>Baseline</time_frame>
    <description>Lens relocation after 10 blinks, after 30ยบ rotation mislocation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rotational Recovery After Lens Mislocation</measure>
    <time_frame>1 month</time_frame>
    <description>Lens relocation after 10 blinks, after 30ยบ rotation mislocation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Astigmatism Bilateral</condition>
  <arm_group>
    <arm_group_label>Comfilcon A (test)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants were randomized to wear either test or control contact lenses bilaterally for one month during the cross-over study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Senofilcon C (control)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants were randomized to wear either test or control contact lenses bilaterally for one month during the cross-over study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Comfilcon A (test)</intervention_name>
    <description>Daily wear contact lenses</description>
    <arm_group_label>Comfilcon A (test)</arm_group_label>
    <arm_group_label>Senofilcon C (control)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Senofilcon C (control)</intervention_name>
    <description>Daily wear contact lenses</description>
    <arm_group_label>Comfilcon A (test)</arm_group_label>
    <arm_group_label>Senofilcon C (control)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        A person is eligible for inclusion in the study if he/she:

          1. Is at least 17 years of age and has full legal capacity to volunteer;

          2. Has had a self-reported oculo-visual examination in the last two years.

          3. Has read and signed an information consent letter;

          4. Is willing and able to follow instructions and maintain the appointment schedule;

          5. Is an adapted soft contact lens wearer, who currently wears contact lenses for a
             minimum 3 days/week and 8 hours/day AND who anticipates no difficulty wearing CLs for
             6 days/week, 10 hours /day.

          6. Is willing to wear contact lens in both eyes for the duration of the study;

          7. Has a minimum astigmatism of - 0.75, determined by refraction;

          8. Can be fit with the two study contact lens types in the powers available;

          9. Has a distance visual acuity of 0.20 logMAR (approx 20/30) or better, determined by
             refraction;

         10. Can achieve a distance visual acuity of 0.20 logMAR (approx 20/30) or better in each
             eye with the study contact lenses.

         11. Has clear corneas and no active* ocular disease;

        Exclusion Criteria:

        A person will be excluded from the study if he/she:

          1. Is participating in any concurrent clinical trial;

          2. Has any known active* ocular disease and/or infection;

          3. Has a systemic condition that in the opinion of the investigator may affect a study
             measure;

          4. Is using any systemic or topical medications that in the opinion of the investigator
             may affect a study measure;

          5. Has known sensitivity to fluorescein dye or products to be used in the study;

          6. Appears to have any active* ocular pathology, ocular anomaly or severe insufficiency
             of lacrimal secretion (severe dry eye) that would affect the wearing of contact
             lenses;

          7. Is pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal
             confirmation at the screening visit);

          8. Is aphakic;

          9. Has undergone refractive error surgery;

         10. Has participated in the previous QUENA study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lyndon Jones, PhD FCOptom</last_name>
    <role>Principal Investigator</role>
    <affiliation>Director, Centre for Ocular Research and Education</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Of Waterloo</name>
      <address>
        <city>Waterloo</city>
        <state>Ontario</state>
        <zip>N2L 3G1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>September 19, 2018</study_first_submitted>
  <study_first_submitted_qc>September 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 26, 2018</study_first_posted>
  <results_first_submitted>June 9, 2020</results_first_submitted>
  <results_first_submitted_qc>June 9, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">June 26, 2020</results_first_posted>
  <last_update_submitted>June 9, 2020</last_update_submitted>
  <last_update_submitted_qc>June 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 19, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/28/NCT03684928/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Comfilcon A (Test) Then Senofilcon A (Control)</title>
          <description>Participants were randomized to wear comfilcon A contact lenses first then or senofilcon C contact lenses bilaterally for one month during the cross-over study.
Comfilcon A (test): Daily wear contact lenses
Senofilcon C: Daily wear contact lenses</description>
        </group>
        <group group_id="P2">
          <title>Senofilcon C (Control) Then Comfilcon A (Test)</title>
          <description>Participants were randomized to wear Senofilcon C control contact lenses first then Comfilcon A contact lenses bilaterally for one month during the cross-over study.
Comfilcon A (test): Daily wear contact lenses
Senofilcon C: Daily wear contact lenses</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Second Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21">Two participants discontinued between the first intervention and second intervention.</participants>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Soft Tissue Injury</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Overall Study</title>
          <description>Total Participants</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="45"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.4" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Ease of Insertion(Handling)</title>
        <description>Subjective ratings of ease of insertion for each pair of lenses (scale: 0-10; 0= Very difficult,10 = Very easy)</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A (Test)</title>
            <description>Participants were randomized to wear comfilcon A contact lenses bilaterally for one month during the cross-over study.
Comfilcon A (test): Daily wear contact lenses</description>
          </group>
          <group group_id="O2">
            <title>Senofilcon C (Control)</title>
            <description>Participants were randomized to wear Senofilcon C control contact lenses bilaterally for one month during the cross-over study.
Senofilcon C: Daily wear contact lenses</description>
          </group>
        </group_list>
        <measure>
          <title>Ease of Insertion(Handling)</title>
          <description>Subjective ratings of ease of insertion for each pair of lenses (scale: 0-10; 0= Very difficult,10 = Very easy)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.1" spread="1.2"/>
                    <measurement group_id="O2" value="9.2" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Ease of Insertion (Handling)</title>
        <description>Subjective ratings of ease of insertion for each pair of lenses (scale: 0-10; 0= Very difficult,10 = Very easy)</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A (Test)</title>
            <description>Participants were randomized to wear comfilcon A contact lenses bilaterally for one month during the cross-over study.
Comfilcon A (test): Daily wear contact lenses</description>
          </group>
          <group group_id="O2">
            <title>Senofilcon C (Control)</title>
            <description>Participants were randomized to wear Senofilcon C control contact lenses bilaterally for one month during the cross-over study.
Senofilcon C: Daily wear contact lenses</description>
          </group>
        </group_list>
        <measure>
          <title>Ease of Insertion (Handling)</title>
          <description>Subjective ratings of ease of insertion for each pair of lenses (scale: 0-10; 0= Very difficult,10 = Very easy)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.9" spread="1.1"/>
                    <measurement group_id="O2" value="8.5" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Ease of Insertion(Handling)</title>
        <description>Subjective ratings of ease of insertion for each pair of lenses (scale: 0-10; 0= Very difficult,10 = Very easy)</description>
        <time_frame>1 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A (Test)</title>
            <description>Participants were randomized to wear comfilcon A contact lenses bilaterally for one month during the cross-over study.
Comfilcon A (test): Daily wear contact lenses</description>
          </group>
          <group group_id="O2">
            <title>Senofilcon C (Control)</title>
            <description>Participants were randomized to wear Senofilcon C control contact lenses bilaterally for one month during the cross-over study.
Senofilcon C: Daily wear contact lenses</description>
          </group>
        </group_list>
        <measure>
          <title>Ease of Insertion(Handling)</title>
          <description>Subjective ratings of ease of insertion for each pair of lenses (scale: 0-10; 0= Very difficult,10 = Very easy)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.8" spread="1.3"/>
                    <measurement group_id="O2" value="8.5" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rotational Recovery After Lens Mislocation</title>
        <description>Lens relocation after 10 blinks, after 30ยบ rotation mislocation</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A (Test)</title>
            <description>Participants were randomized to wear comfilcon A contact lenses bilaterally for one month during the cross-over study.
Comfilcon A (test): Daily wear contact lenses</description>
          </group>
          <group group_id="O2">
            <title>Senofilcon C (Control)</title>
            <description>Participants were randomized to wear Senofilcon C control contact lenses bilaterally for one month during the cross-over study.
Senofilcon C: Daily wear contact lenses</description>
          </group>
        </group_list>
        <measure>
          <title>Rotational Recovery After Lens Mislocation</title>
          <description>Lens relocation after 10 blinks, after 30ยบ rotation mislocation</description>
          <units>Degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Nasal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27" spread="4"/>
                    <measurement group_id="O2" value="23" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Temporal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23" spread="8"/>
                    <measurement group_id="O2" value="19" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rotational Recovery After Lens Mislocation</title>
        <description>Lens relocation after 10 blinks, after 30ยบ rotation mislocation.</description>
        <time_frame>1 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A (Test)</title>
            <description>Participants were randomized to wear comfilcon A contact lenses bilaterally for one month during the cross-over study.
Comfilcon A (test): Daily wear contact lenses</description>
          </group>
          <group group_id="O2">
            <title>Senofilcon C (Control)</title>
            <description>Participants were randomized to wear Senofilcon C control contact lenses bilaterally for one month during the cross-over study.
Senofilcon C: Daily wear contact lenses</description>
          </group>
        </group_list>
        <measure>
          <title>Rotational Recovery After Lens Mislocation</title>
          <description>Lens relocation after 10 blinks, after 30ยบ rotation mislocation.</description>
          <units>Degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Nasal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26" spread="6"/>
                    <measurement group_id="O2" value="23" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Temporal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23" spread="7"/>
                    <measurement group_id="O2" value="18" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From baseline up to one month for each intervention.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Comfilcon A (Test)</title>
          <description>Participants were randomized to wear comfilcon A contact lenses bilaterally for one month during the cross-over study.
Comfilcon A (test): Daily wear contact lenses</description>
        </group>
        <group group_id="E2">
          <title>Senofilcon C (Control)</title>
          <description>Participants were randomized to wear Senofilcon C control contact lenses bilaterally for one month during the cross-over study.
Senofilcon C: Daily wear contact lenses</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="45"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jose A. Vega, O.D., MSc., FAAO</name_or_title>
      <organization>CooperVision,Inc.</organization>
      <phone>925 621 3761</phone>
      <email>javega@coopervision.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

